Modality
3 known investors
Modality.AI develops an AI-based multimodal assessment platform that uses app-collected data to help diagnose and monitor neurodegenerative diseases such as ALS. It serves clinicians and patients, aiming to reduce reliance on in-clinic evaluations for conditions like ALS.
Founders & leadership
DS
David Suendermann-OeftCo-founder & CEO
DP
David PautlerCo-founder & CTO
Investors · 3
Competitors · 5
by search overlapViso6 shared keywordsViso.ai offers a computer vision platform with two products: Visonow, a tool to build vision agents from a text prompt and video, and Visosuite, an enterprise operating system to connect cameras across sites and run governed, agentic vision workflows at scale. It serves enterprises across multiple industries for use cases like monitoring, inspection, and safety alerting.
Definitive Healthcare6 shared keywordsDefinitive Healthcare provides a healthcare commercial intelligence platform with all-payor claims data, reference data, and analytics on hospitals, physicians, payors, procedures, diagnoses, and prescriptions. It serves life sciences companies, healthcare providers, and healthcare-adjacent businesses for market analysis, targeting, and sales and marketing efforts, with an AI-powered intelligence product announced for Winter 2026.
Itnonline5 shared keywordsITN (Imaging Technology News) is an online trade publication covering radiology and medical imaging, reporting on news, products, and clinical developments across modalities like CT, ultrasound, and breast imaging. It serves radiology professionals, imaging departments, and healthcare technology providers.
Massive Bio5 shared keywordsMassive Bio operates an AI-based platform that matches cancer patients with oncology clinical trials and provides concierge support throughout the trial process. It serves patients across the U.S., Canada, Latin America, and Europe, and works with pharma and CRO customers, patient advocacy organizations, and the National Cancer Institute's network of cancer centers.
Diabetomics5 shared keywordsModalityDx develops quantitative point-of-care diagnostic tests using molecular biomarkers and data science to detect and assess treatment response for diseases including diabetes, maternal health conditions, and autoimmune disorders. The company also supports pharmaceutical firms in drug development and therapeutic efficacy assessment.
Companies competing with Modality for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Modality do?
- Modality.AI develops an AI-based multimodal assessment platform that uses app-collected data to help diagnose and monitor neurodegenerative diseases such as ALS. It serves clinicians and patients, aiming to reduce reliance on in-clinic evaluations for conditions like ALS.
- Who founded Modality?
- Modality was founded by David Suendermann-Oeft, David Pautler.
- Who are Modality's investors?
- Modality's investors include CARELA Holding GmbH, Lair East Labs, Novalis Biotech.